Oruka Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: ORKA · Form: 8-K · Filed: Jun 3, 2025 · CIK: 907654
| Field | Detail |
|---|---|
| Company | Oruka Therapeutics, Inc. (ORKA) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Oruka Therapeutics had a shareholder vote on June 2nd. Details TBD.
AI Summary
Oruka Therapeutics, Inc. filed an 8-K on June 3, 2025, reporting on matters submitted to a vote of security holders as of June 2, 2025. The filing indicates a corporate action or shareholder vote took place, but specific details of the vote, resolutions, or outcomes are not provided in this excerpt.
Why It Matters
This filing signals a significant corporate event requiring shareholder approval, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: medium — The filing indicates a shareholder vote, which can introduce uncertainty or signal significant corporate changes.
Key Players & Entities
- Oruka Therapeutics, Inc. (company) — Registrant
- June 2, 2025 (date) — Date of earliest event reported
- June 3, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 36-3855489 (identifier) — IRS Employer Identification No.
- 855 Oak Grove Avenue Suite 100 Menlo Park, California 94025 (address) — Principal executive offices
- ARCA biopharma, Inc. (company) — Former company name
- NUVELO INC (company) — Former company name
- HYSEQ INC (company) — Former company name
FAQ
What specific matters were submitted to a vote of Oruka Therapeutics' security holders?
The filing states that matters were submitted to a vote of security holders, but does not specify what those matters were.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 2, 2025.
What is the principal executive office address for Oruka Therapeutics, Inc.?
The principal executive office is located at 855 Oak Grove Avenue Suite 100, Menlo Park, California 94025.
What is Oruka Therapeutics, Inc.'s state of incorporation?
Oruka Therapeutics, Inc. is incorporated in Delaware.
Has Oruka Therapeutics, Inc. operated under any former names?
Yes, Oruka Therapeutics, Inc. has operated under the former names ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding Oruka Therapeutics, Inc. (ORKA).